We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATMCU
151
DELISTED
AlphaTime Acquisition Corp Unit
ATMCU
$5.91M 0.15%
+585,000
New +$5.91M
GSQB
152
DELISTED
G Squared Ascend II Inc.
GSQB
$5.87M 0.15%
578,503
+296,729
+105% +$2.98M
SKYA
153
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
$5.83M 0.15%
579,773
+497,285
+603% +$4.95M
GVCI
154
DELISTED
Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares
GVCI
$5.7M 0.15%
549,709
-113,264
-17% -$1.16M
CBRG
155
DELISTED
Chain Bridge I Class A Ordinary Shares
CBRG
$5.59M 0.14%
544,235
+528,084
+3,270% +$5.37M
BOCN
156
DELISTED
Blue Ocean Acquisition Corp Class A Ordinary Shares
BOCN
$5.58M 0.14%
544,968
+510,578
+1,485% +$5.18M
RRAC
157
DELISTED
Rigel Resource Acquisition Corp.
RRAC
$5.48M 0.14%
532,729
+201,541
+61% +$2.05M
LATG
158
DELISTED
Chenghe Acquisition I Co. Class A Ordinary Shares
LATG
$5.36M 0.14%
522,464
+7,151
+1% +$72.8K
LCW
159
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
$5.24M 0.14%
+519,200
New +$5.2M
MAQC
160
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
$5.19M 0.13%
497,938
+1,297
+0.3% +$13.5K
MITA
161
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
$5.13M 0.13%
511,095
+89,091
+21% +$887K
BRLS icon
162
Borealis Foods
BRLS
$17.9M
$4.95M 0.13%
478,813
+180,618
+61% +$1.84M
PEGR
163
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$4.94M 0.13%
+490,537
New +$4.87M
BNZI icon
164
Banzai International
BNZI
$6.03M
$4.89M 0.13%
48
-107
-69% -$10.7M
QFTA
165
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
$4.87M 0.13%
484,826
+263,391
+119% +$2.61M
SVII
166
DELISTED
Spring Valley Acquisition Corp II
SVII
$4.81M 0.12%
+474,996
New +$4.8M
NFYS
167
DELISTED
Enphys Acquisition Corp.
NFYS
$4.49M 0.12%
+447,134
New +$4.42M
AERT
168
Aeries Technology
AERT
$36.8M
$4.4M 0.11%
54,142
+14,287
+36% +$1.15M
SVNA
169
DELISTED
7 Acquisition Corp
SVNA
$4.36M 0.11%
425,801
+481
+0.1% +$4.89K
OCAX
170
DELISTED
OCA Acquisition Corp. Class A Common Stock
OCAX
$4.27M 0.11%
+415,860
New +$4.22M
RCFA
171
DELISTED
Perception Capital Corp. IV
RCFA
$4.26M 0.11%
415,016
+351,121
+550% +$3.57M
EVE
172
DELISTED
EVe Mobility Acquisition Corp
EVE
$4.18M 0.11%
405,395
+283,388
+232% +$2.88M
IXAQ
173
DELISTED
IX Acquisition Corp. Class A Ordinary Share
IXAQ
$3.98M 0.1%
392,193
+21,762
+6% +$218K
CREC
174
DELISTED
Crescera Capital Acquisition Corp Class A Ordinary Shares
CREC
$3.94M 0.1%
384,993
+262,579
+215% +$2.66M
CTOR
175
Citius Oncology
CTOR
$53.4M
$3.93M 0.1%
+386,672
New +$3.92M

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.